Patents by Inventor Harry P. Zhabilov

Harry P. Zhabilov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral compositions comprising lysine-rich histone fractions prepared by pepsin treatment of thymic cell nuclei
    Patent number: 7625565
    Abstract: This invention relates to the area of immunology and virology, and specifically relates to compositions obtainable from mammalian thymus cells which are useful as diagnostics, vaccines, and therapeutics for human immunodeficiency virus (HIV) infection and related diseases such as acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). The diagnostic, vaccination, and therapeutic methods, and devices, using these compositions are also disclosed.
    Type: Grant
    Filed: January 3, 2003
    Date of Patent: December 1, 2009
    Assignee: Viral Genetics, Inc.
    Inventors: Harry P. Zhabilov, Jordanka Zhabilov, legal representative, Harry H. Zhabilov
  • Compositions and methods for detecting and treating acquired immunodeficiency syndrome
    Publication number: 20040018639
    Abstract: This invention relates to the area of immunology and virology, and specifically relates to compositions obtainable from mammalian thymus cells which are useful as diagnostics, vaccines, and therapeutics for human immunodeficiency virus (HIV) infection and related diseases such as acquired immunodeficiency syndrome (AIDS) and AIDS-related complex (ARC). The diagnostic, vaccination, and therapeutic methods, and devices, using these compositions are also disclosed.
    Type: Application
    Filed: January 3, 2003
    Publication date: January 29, 2004
    Inventors: Harry P. Zhabilov, Haig Keledjian
  • Compositions, processes for their preparation and method for treatment of neoplasms
    Patent number: 4415553
    Abstract: The invention comprises preparations for the treatment of neoplasms, the methods of treatment of neoplasms using such preparations, and processes for preparing such preparations, including the step of selective enzymatic degradation of the nuclei of cancer cells.The invention further comprises the method of treating patients suffering from neoplasms with immunomodulating agents obtained by isolating the genetically active components of cancer cell nuclei obtained from cancer tissue, subsequently recombining them by specific hybridization steps to prepare a vaccine therefrom, and intravenously, intraperitoneally and/or intramuscularly administering the resulting vaccine product to patients.
    Type: Grant
    Filed: March 5, 1980
    Date of Patent: November 15, 1983
    Assignee: DSO "Pharmachim"
    Inventors: Harry P. Zhabilov, Todor Y. Karavassileff